• Home
  • Practice Focus
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
    • How I Do It
    • TRIO Best Practices
  • Business of Medicine
    • Health Policy
    • Legal Matters
    • Practice Management
    • Tech Talk
    • AI
  • Literature Reviews
    • Facial Plastic/Reconstructive
    • Head and Neck
    • Laryngology
    • Otology/Neurotology
    • Pediatric
    • Rhinology
    • Sleep Medicine
  • Career
    • Medical Education
    • Professional Development
    • Resident Focus
  • ENT Perspectives
    • ENT Expressions
    • Everyday Ethics
    • From TRIO
    • The Great Debate
    • Letter From the Editor
    • Rx: Wellness
    • The Voice
    • Viewpoint
  • TRIO Resources
    • Triological Society
    • The Laryngoscope
    • Laryngoscope Investigative Otolaryngology
    • TRIO Combined Sections Meetings
    • COSM
    • Related Otolaryngology Events
  • Search

Otolaryngologists See Immunotherapy as Hope for Patients with Head and Neck Cancer

by Nikki Kean • February 6, 2020

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
Print-Friendly Version

Changes in AJCC Guidelines

Another development has been the release of American Joint Commission on Cancer (AJCC) guidelines for the treatment of oral and oropharyngeal squamous cell carcinomas, said Maie A. St. John, MD, PhD, the Thomas C. Calcaterra Chair in head and neck surgery at the University of California, Los Angeles (UCLA).

You Might Also Like

  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
  • New Immunotherapy Improves Survival Rates in Squamous Cell Carcinoma of the Head and Neck
  • Researchers Find Strong Association Between TERT Antigens and Elevated B Cells in Head and Neck Cancer
  • Post-Treatment Persistence of Oral HPV in Head and Neck Cancer Predicts Recurrence, Death
Explore This Issue
February 2020

The new guidelines (CA Cancer J Clin. 2017;67:93-99) feature modifications and additions to staging head and neck cancer that were the result of “a multitude of studies,” said Dr. St. John, who is also co-director of the UCLA Head and Neck Cancer Program at the Jonsson Comprehensive Cancer Center. These include using depth of tumor invasion as a criterion for T designation, as well as novel staging systems for high-risk human papillomavirus (HPV)-positive cancers, and the inclusion of extranodal extension.

Within our lifetimes, I would suggest that we may also be giving the PD-1 inhibitors, because there are oral and subcutaneous versions coming on the market that look promising. —Robert L. Ferris, MD, PhD

“We knew from clinical experience and studies that patients with HPV-positive tumors had better outcomes than patients with HPV-negative tumors,” Dr. St. John said. “The new guidelines create a separate staging system for HPV-positive tumors, allowing more precise therapy for these patients. With advances in immunotherapy, a multitude of new possibilities are now in the pipeline for treating recurrent and metastatic head and neck tumors.”

Dr. St. John agreed with Dr. Grandis that treating head and neck cancers requires real-time multidisciplinary care. “A increasing number of institutions have signed on to this, where patients come in and are seen by a multitude of specialists in one afternoon,” Dr. St. John said. That strategy is also driven by the complexity of head and neck cancers. The tumors “occur in an anatomical region unmatched in the number of physiological functions potentially affected,” she explained.

Dr. St. John cautioned, however, against taking too narrow an approach. “The care of the head and neck cancer patient is the art of caring for the whole patient,” she said. “That should include multimodal surgical and medical management, aesthetic considerations, nutrition, pain management, and psychosocial support.”


Nikki Kean is a freelance medical writer based in New Jersey.

Farther Afield, Hints of NF2 Breakthrough

© Living Art Enterprises, LLC / Science Source

© Living Art Enterprises, LLC / Science Source

For some head and neck tumors, identifying signs of progress may require looking a bit beyond the core otolaryngology literature.

Pages: 1 2 3 4 5 | Single Page

Filed Under: Features, Head and Neck Tagged With: clinical care, head and neck cancerIssue: February 2020

You Might Also Like:

  • A Look at Immunotherapy’s Potential for Head and Neck Cancer Treatment
  • New Immunotherapy Improves Survival Rates in Squamous Cell Carcinoma of the Head and Neck
  • Researchers Find Strong Association Between TERT Antigens and Elevated B Cells in Head and Neck Cancer
  • Post-Treatment Persistence of Oral HPV in Head and Neck Cancer Predicts Recurrence, Death

The Triological SocietyENTtoday is a publication of The Triological Society.

Polls

Would you choose a concierge physician as your PCP?

View Results

Loading ... Loading ...
  • Polls Archive

Top Articles for Residents

  • Applications Open for Resident Members of ENTtoday Edit Board
  • How To Provide Helpful Feedback To Residents
  • Call for Resident Bowl Questions
  • New Standardized Otolaryngology Curriculum Launching July 1 Should Be Valuable Resource For Physicians Around The World
  • Do Training Programs Give Otolaryngology Residents the Necessary Tools to Do Productive Research?
  • Popular this Week
  • Most Popular
  • Most Recent
    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Keeping Watch for Skin Cancers on the Head and Neck

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Clinical Grading System for Reinke’s Edema

    • The Dramatic Rise in Tongue Tie and Lip Tie Treatment

    • Rating Laryngopharyngeal Reflux Severity: How Do Two Common Instruments Compare?

    • Is Middle Ear Pressure Affected by Continuous Positive Airway Pressure Use?

    • Otolaryngologists Are Still Debating the Effectiveness of Tongue Tie Treatment

    • Complications for When Physicians Change a Maiden Name

    • Excitement Around Gene Therapy for Hearing Restoration
    • “Small” Acts of Kindness
    • How To: Endoscopic Total Maxillectomy Without Facial Skin Incision
    • Science Communities Must Speak Out When Policies Threaten Health and Safety
    • Observation Most Cost-Effective in Addressing AECRS in Absence of Bacterial Infection

Follow Us

  • Contact Us
  • About Us
  • Advertise
  • The Triological Society
  • The Laryngoscope
  • Laryngoscope Investigative Otolaryngology
  • Privacy Policy
  • Terms of Use
  • Cookies

Wiley

Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1559-4939